Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy-Reference-Cited by-同舟云学术

Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy

Published:2016-01-14 Issue:2 Volume:127 Page:200-207
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Ammann Eric M.¹^ORCID,Jones Michael P.²,Link Brian K.³,Carnahan Ryan M.¹,Winiecki Scott K.⁴^ORCID,Torner James C.¹,McDowell Bradley D.⁵,Fireman Bruce H.⁶,Chrischilles Elizabeth A.¹⁵

Affiliation:

1. Department of Epidemiology and

2. Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA;

3. Division of Hematology, Oncology and Blood & Marrow Transplantation, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA;

4. Office of Biostatistics and Epidemiology, Center for Biologics Evaluation & Research, US Food and Drug Administration, Silver Spring, MD;

5. Population Research Core, Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA; and

6. Division of Research, Kaiser Permanente Northern California, Oakland, CA

Abstract

Key Points Acute myocardial infarction and ischemic stroke risk was 3 times higher during days 0 to 1 following IVIg treatment in patients with secondary hypogammaglobulinemia. In patients treated with IVIg for 1 year, the estimated increase in the absolute risk of a severe thromboembolic event was ∼1%.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/127/2/200/1351924/200.pdf

Reference50 articles.

1. History of immunoglobulin replacement.;Eibl;Immunol Allergy Clin North Am,2008

2. Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis.;Raanani;Leuk Lymphoma,2009

3. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies.;Orange;Clin Immunol,2010

4. Use of intravenous immunoglobulin to prevent or treat infections in persons with immune deficiency.;Lee;Annu Rev Med,1997

5. FDA Medwatch Safety Alerts for Human Medical Products. Immune globulin intravenous (human) [IGIV]. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154633.htm. Accessed September 19, 2011

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune thrombocytopenia increases the risk of thrombosis: A two-sample Mendelian randomization study;International Journal of Cardiology;2024-11

2. Antibodies and complement are key drivers of thrombosis;Immunity;2024-09

3. IgG replacement in multiple myeloma;Blood Cancer Journal;2024-07-25

4. Optimal Weight-Based Dosing of Intravenous Immunoglobulin (IVIG) among Overweight and Obese Patients;Current Drug Therapy;2024-06

5. Evaluation of the Efficacy and Safety of Intravenous Immunoglobulin (IVIG) in Moderate-to-Severe Hospitalized COVID-19 Patients: A Randomized, Open-Label Parallel-Group Study;Canadian Journal of Infectious Diseases and Medical Microbiology;2024-05-21